Mistakes to Be Avoided When Preparing a Drug Launch
The launch of a new product can be a daunting task. The main reason this happens is that no matter […]
Mistakes to Be Avoided When Preparing a Drug Launch Read Post »
Insights
October 2019
Insights
Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984
This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under
Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 Read Post »
Customer Success Stories, Insights, Tips, Tricks, and Case Studies
Customer Success: How do we identify generic entrants before they get FDA approval?
DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants
Customer Success: How do we identify generic entrants before they get FDA approval? Read Post »
Featured, Insights, Update
DrugPatentWatch Headlines Swissbiotech Annual Report
The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very
DrugPatentWatch Headlines Swissbiotech Annual Report Read Post »
Insights
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection
This article was originally published by Christopher M. Holman* in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection Read Post »
